Trademark Overview
On Monday, April 1, 2024, a trademark application was filed for GENTIBIO with the United States Patent and Trademark Office. The USPTO has given the GENTIBIO trademark a serial number of 98478168. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 1, 2024. This trademark is owned by GentiBio, Inc.. The GENTIBIO trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacture of pharmaceuticals and therapies for others; Custom manufacturing of biological cells; Consultation in the field of custom manufacture of pharmaceuticals, therapies and biological cells
Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders, allergic diseases and disorders, autoimmune diseases and disorders, acute illness, diabetes, stroke, inflammation and inflammatory disease, respiratory and infectious diseases, acute respiratory distress illness, immunological disorders and metabolic diseases; Autologous therapies; Allogeneic therapies; Virotherapies; Human cells for medical purposes; Cells for medical therapy use; Cultured human cells for therapeutic use
Scientific research; Pharmaceutical and therapeutic research; Medical research; Engineering of biological cells; Genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering
